Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Feb 26, 2021Finch Therapeutics Group, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Oct 31, 2024Removed from listing - SEC Form 25 filed.
SourceFNCH stopped trading
Oct 31, 2024FNCH is linked to Finch Therapeutics Group, Inc. and ended with final status "delisted".
Source
Entity Graph
Finch Therapeutics Group, Inc.issuedFNCH
FNCHlisted onNASDAQ
FNCHresulted inunknown
Source-Backed Claims
- On October 17, 2024, Finch Therapeutics Group, Inc. initiated the delisting of its common stock from the Nasdaq Global Select Market.8-K
- Finch Therapeutics Group, Inc. intends to file a Form 25 with the SEC on or about October 31, 2024, to effect the delisting of its common stock from Nasdaq.8-K
- The removal of Finch Therapeutics Group, Inc.'s common stock from Nasdaq will be effective 10 days after the filing of Form 25.8-K
- The withdrawal of registration of Finch Therapeutics Group, Inc.'s common stock under Section 12(b) of the Exchange Act is expected 90 days after the filing of Form 25.8-K
- Finch Therapeutics Group, Inc. plans to file a Form 15 with the SEC to deregister its common stock under Sections 12(g) and 15(d) of the Exchange Act following its delisting from Nasdaq.8-K
- Finch Therapeutics Group, Inc.'s common stock has been trading on a market operated by OTC Markets Group Inc. since being suspended from Nasdaq on May 28, 2024.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.